Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.

Facompre ND, El-Bayoumy K, Sun YW, Pinto JT, Sinha R.

Cancer Prev Res (Phila). 2010 Aug;3(8):975-84. doi: 10.1158/1940-6207.CAPR-10-0054. Epub 2010 Jul 6.

2.

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. Review.

PMID:
12431817
3.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
4.

Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.

Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S.

J Cell Biochem. 2006 Aug 15;98(6):1408-23. Review.

PMID:
16619263
5.

Prostate cancer: Re-focusing on androgen receptor signaling.

Nieto M, Finn S, Loda M, Hahn WC.

Int J Biochem Cell Biol. 2007;39(9):1562-8. Epub 2007 Jan 20. Review.

6.
7.

The molecular underpinnings of prostate cancer: impacts on management and pathology practice.

Rodrigues DN, Boysen G, Sumanasuriya S, Seed G, Marzo AM, de Bono J.

J Pathol. 2017 Jan;241(2):173-182. doi: 10.1002/path.4826. Epub 2016 Dec 1. Review.

PMID:
27753448
8.

Growth factor and signaling pathways and their relevance to prostate cancer therapeutics.

Wozney JL, Antonarakis ES.

Cancer Metastasis Rev. 2014 Sep;33(2-3):581-94. doi: 10.1007/s10555-013-9475-z. Review.

9.

ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.

Mahajan K, Mahajan NP.

Oncogene. 2015 Aug 6;34(32):4162-7. doi: 10.1038/onc.2014.350. Epub 2014 Oct 27. Review.

10.

Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.

Kulik G.

Asian J Androl. 2015 May-Jun;17(3):471-4. doi: 10.4103/1008-682X.143749. Review.

11.

Androgen receptor on the move: boarding the microtubule expressway to the nucleus.

Thadani-Mulero M, Nanus DM, Giannakakou P.

Cancer Res. 2012 Sep 15;72(18):4611-5. doi: 10.1158/0008-5472.CAN-12-0783. Review.

12.

Molecular pathways and targets in prostate cancer.

Shtivelman E, Beer TM, Evans CP.

Oncotarget. 2014 Sep 15;5(17):7217-59. Review.

13.

Signaling lansdscape of prostate cancer.

Lin X, Aslam A, Attar R, Yaylim I, Qureshi MZ, Hasnain S, Qadir MI, Farooqi AA.

Cell Mol Biol (Noisy-le-grand). 2016 Jan 19;62(1):45-50. Review.

PMID:
26828986
14.

Prolactin regulation of the prostate gland: a female player in a male game.

Goffin V, Hoang DT, Bogorad RL, Nevalainen MT.

Nat Rev Urol. 2011 Oct 4;8(11):597-607. doi: 10.1038/nrurol.2011.143. Review.

PMID:
21971318
15.

PTEN-mediated pathways and their association with treatment-resistant prostate cancer.

Uzoh CC, Perks CM, Bahl A, Holly JM, Sugiono M, Persad RA.

BJU Int. 2009 Aug;104(4):556-61. doi: 10.1111/j.1464-410X.2009.08411.x. Epub 2009 Feb 13. Review. No abstract available.

16.

Novel targets for prostate cancer chemoprevention.

Sarkar FH, Li Y, Wang Z, Kong D.

Endocr Relat Cancer. 2010 Aug 16;17(3):R195-212. doi: 10.1677/ERC-10-0074. Print 2010 Sep. Review.

17.

Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.

Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ.

Amino Acids. 2011 Jun;41(1):29-41. doi: 10.1007/s00726-010-0578-3. Epub 2010 Apr 10. Review.

18.

The emerging roles of orphan nuclear receptors in prostate cancer.

Wu D, Cheung A, Wang Y, Yu S, Chan FL.

Biochim Biophys Acta. 2016 Aug;1866(1):23-36. doi: 10.1016/j.bbcan.2016.06.001. Epub 2016 Jun 2. Review.

PMID:
27264242
19.

Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.

Mattmann ME, Stoops SL, Lindsley CW.

Expert Opin Ther Pat. 2011 Sep;21(9):1309-38. doi: 10.1517/13543776.2011.587959. Epub 2011 Jun 2. Review.

20.

Translating insights of AR signaling from mouse models.

Carver BS.

Transl Androl Urol. 2013 Sep;2(3):197-201. doi: 10.3978/j.issn.2223-4683.2013.09.17. Review.

Supplemental Content

Support Center